Point-of-Care (POC) Infectious Disease Diagnostics Market Global Industry Insights, and Forecast till 2025
Point-of-Care (POC) Infectious Disease Diagnostics Market
Point of care diagnosis involves
testing the samples right away to enable quick diagnosis and make the
appropriate treatment decisions. Since they can become fatal against the immune
system, infectious diseases frequently require early diagnosis. Early disease
detection is made possible by point-of-care diagnostics, which also has a
significant impact on how well a disease is treated medically. Advanced
point-of-care diagnostics technologies like lateral flow, agglutination assays,
and solid phase are combined with cutting-edge features like handheld device
portability.
The gold standard in
biochemistry, haematology, and diagnostics is centralised laboratory testing.
Point-of-care diagnostics have a number of benefits, including reduced costs,
ease of use in remote locations, and technological advancements. Patients can
use small, handheld point-of-care gadgets because they are portable. These
tests employ capillary or fingerstick samples, which are applied directly to
the instrument and do not require sample containers.
The future of point-of-care
diagnostics has changed as a result of technologies like lateral flow and various
molecular assays integrated with Point-of-Care
(POC) Infectious Disease Diagnostics Market. For instance,
immunoassays, which are economical and yield quick results, are products
provided by renowned manufacturers like Alere and Roche. Additionally, Becton,
Dickinson, and Company provided the point-of-care BD FACSPresto system for
HIV/AIDS in 2014. It provides CD4 T lymphocyte and haemoglobin concentration
percentage results. Additionally, Infectious Disease Research Institute (IDRI)
created a fusion antigen in January 2017 that is utilised in a diagnostic test
for Chagas disease produced by InBios International, Inc.
Comments
Post a Comment